Sudapyridine (WX-081)

sudapyridine · Shanghai Jiatan Pharmatech Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sudapyridine (WX-081), covering 2025-02-12 to 2025-06-29. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients [Phase 3]

See pricing